Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000080032 | SCV000111926 | benign | not specified | 2014-02-19 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000080032 | SCV000199989 | benign | not specified | 2012-05-07 | criteria provided, single submitter | clinical testing | "Ile159Ile in Exon 04 of PRPS1: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence, and has been identified in 0.8% (42/5545) of Eu ropean American chromosomes from a broad population by the NHLBI Exome Sequencin g Project (http://evs.gs.washington.edu/EVS; dbSNP rs61752962)." |
Invitae | RCV000204144 | SCV000262494 | benign | Charcot-Marie-Tooth Neuropathy X | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000080032 | SCV000309180 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000362584 | SCV000481430 | benign | Hearing loss, X-linked 1 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV000402522 | SCV000481431 | benign | Phosphoribosylpyrophosphate synthetase superactivity | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV000308646 | SCV000481432 | benign | Arts syndrome | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Gene |
RCV001664331 | SCV001874703 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000308646 | SCV002031950 | benign | Arts syndrome | 2021-10-25 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001789127 | SCV002031951 | benign | Charcot-Marie-Tooth disease X-linked recessive 5 | 2021-10-25 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000362584 | SCV002031953 | benign | Hearing loss, X-linked 1 | 2021-10-25 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000402522 | SCV002031954 | benign | Phosphoribosylpyrophosphate synthetase superactivity | 2021-10-25 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002498407 | SCV002805045 | likely benign | Arts syndrome; Hearing loss, X-linked 1; Charcot-Marie-Tooth disease X-linked recessive 5; Phosphoribosylpyrophosphate synthetase superactivity | 2021-07-21 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001664331 | SCV003799602 | benign | not provided | 2023-10-18 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000080032 | SCV001918956 | benign | not specified | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV001664331 | SCV001963181 | likely benign | not provided | no assertion criteria provided | clinical testing |